Study of Efficacy and Safety of Dabrafenib and Trametinib Combination Therapy in Japanese Patients With BRAF V600E Stage IV NSCLC
Clinical trial NCT02672358 · WITHDRAWN
Trial details
- NCT number
- NCT02672358
- Sponsor
- Novartis Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-03
- Primary completion
- 2019-09-02
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.